PHARMOS OÜ
CopyRegistry data
Legal status
Company ID
16007151VAT code
EE102271054Registered
10/07/2020Share capital
2,500.00 €Activity
Retail sale of pharmaceutical products (47731 - EMTAK 2025)Contacts
Company registration address
Website
-
B
HighReliability
B - High
0 ** during past year
Number of employees
2Credit limit
1-3 k €Credit report
Company's financial performance and creditability assessment.
+18.21 % ** during past year
Taxes
8.3KDebts
-+18.73 % ** during past year
Taxable turnover
85.4K
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Register and
explore Okredo data
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Register and
explore Okredo dataEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Register and
explore Okredo dataNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2022 |
|---|
| 246,570 |
| 123,285 |
| 1,293 |
| 1,293 |
| 647 |
| 0.11 |
| 1.12 |
| 10.04 |
| 24,747 |
| 10.04 |
| 24,747 |
| 11.14 |
| 0.52 |
| 27,437 |
| 30,778 |
| 0 |
| 58,215 |
| 2023 |
|---|
| 274,558 |
| 137,279 |
| 110 |
| 110 |
| 55 |
| 0.03 |
| 4.85 |
| 9.83 |
| 26,999 |
| 9.83 |
| 26,999 |
| 11.29 |
| 0.04 |
| 7,547 |
| 36,577 |
| 0 |
| 44,124 |
| 2024 |
|---|
| 291,526 |
| 145,763 |
| 519 |
| 519 |
| 260 |
| 0.03 |
| 5.22 |
| 10.98 |
| 32,018 |
| 10.98 |
| 32,018 |
| 12.48 |
| 0.18 |
| 8,066 |
| 42,131 |
| 0 |
| 50,197 |
| 2024 |
|---|
| 291,526 |
| 145,763 |
| 519 |
| 519 |
| 260 |
| 0.03 |
| 5.22 |
| 10.98 |
| 32,018 |
| 10.98 |
| 32,018 |
| 12.48 |
| 0.18 |
| 8,066 |
| 42,131 |
| 0 |
| 50,197 |
Register and
explore Okredo dataTurnover (€)
Register and
explore Okredo dataCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Category:
Retail sale of pharmaceutical productsComp. code:
16495021Reg. date:
06/05/2022Turnover:
-No. of employees:
1Category:
Retail sale of pharmaceutical productsComp. code:
16086050Reg. date:
29/10/2020Turnover:
-No. of employees:
2Category:
Retail sale of pharmaceutical productsComp. code:
14853433Reg. date:
21/11/2019Turnover:
-No. of employees:
1Category:
Retail sale of pharmaceutical productsComp. code:
14627458Reg. date:
17/12/2018Turnover:
-No. of employees:
2Category:
Retail sale of pharmaceutical productsComp. code:
14285360Reg. date:
29/06/2017Turnover:
-No. of employees:
2